Issue
Alert me when new journal issues are available via
American society for therapeutic radiology and oncology page 1 Full-Text PDF (24 KB)
Past presidents page 2 Full-Text PDF (59 KB)
Recipients of the ASTRO gold medal page 3 Full-Text PDF (41 KB)
2000 Award winners page 4 Full-Text PDF (31 KB)
2000 ASTRO abstract reviewers page 5 Full-Text PDF (48 KB)
Gold medal tribute pages 6-7 Full-Text PDF (172 KB)
Gold medal tribute pages 8-9 Full-Text PDF (97 KB)
Meeting highlights/special events pages 10-12 Full-Text PDF (219 KB)
Schedule of events pages 13-70 Full-Text PDF (3535 KB)
ASTRO poster listing pages 72-87 Full-Text PDF (1019 KB)
ASTRO Nursing Program Schedule page 88 Full-Text PDF (82 KB)
Association of residents in radiation Oncology (ARRO) page 89 Full-Text PDF (65 KB)
24th ASRT radiation therapy conference in conjunction with ASTRO October 22–25, 2000 Boston, Mass. pages 90-102 Full-Text PDF (886 KB)
SROA program pages 103-106 Full-Text PDF (183 KB)
Commercial exhibitors pages 107-108 Full-Text PDF (142 KB)
Exhibit hall A & B page 109 Full-Text PDF (81 KB)
Exhibit hall auditorium, C & D page 110 Full-Text PDF (52 KB)
Impact of a boost dose of 16 GY on the local control and cosmesis in patients with early breast cancer: The EORTC ‘boost versus no boost’ trial H Bartelink, L Collette, A Fourquet, J.C Horiot, J.J Jager, J.L Peterse, M Pierart, P.M Poortmans, H Struikmans, W Van den Bogaert page 111 Full-Text PDF (118 KB)
Very accelerated versus conventional radiotherapy in HNSCC: Results of the GORTEC 94-02 randomized trial J Bourhis, M Lapeyre, J Tortochaux, M Rives, S Bourdin, T Benassi, J.B Dubois, F Lesaunier, L Geoffrois, P Verrelle, N Daly-Schveitzer, E Bardet, P Wibault, F Eschwege, E Benhamou page 111 Full-Text PDF (118 KB)
Intergroup 0116 (SWOG 9008)- phase III trial of postoperative adjuvant radiochemotherapy for high risk gastric and gastroesophageal junction adenocarcinoma: Evaluation of efficacy and radiotherapy treatment planning S Smalley, J Benedetti, L Gunderson, J Martenson, J Tepper, K Kiel, A Lichter, J Forman, J Macdonald pages 111-112 Full-Text PDF (258 KB)
RTOG protocol 92-02: A phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate G.E Hanks, J.D Lu, M Machtay, V.M Venkatesan, W.H Pinover, R.W Byhardt, S.A Rosenthal page 112 Full-Text PDF (140 KB)
Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410) R Komaki, W Seiferheld, W Curran, C Langer, J.S Lee, S Hauser, B Movasas, T Wasserman, A Russell, R Byhardt, W Sause, J Cox page 113 Full-Text PDF (127 KB)
Preliminary report of RTOG 9508: A phase III trial comparing whole brain irradiation alone versus whole brain irradiation plus stereotactic radiosurgery for patients with two or three unresected brain metastases P.W Sperduto, C Scott, D Andrews, M Schell, M Werner-Wasik, W Demas, J.K Ryu, J Fontanesi, M Rotman, W Curran page 113 Full-Text PDF (127 KB)
Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both P.B Chougule, M Burton-Williams, S Saris, Z Zheng, B Ponte, G Noren, L Alderson, G Friehs, D Wazer, M Epstein page 114 Full-Text PDF (139 KB)
A phase III randomized trial of synchronous radiotherapy with temozolomide in brain metastases E Paraskevaidis, D Antonadou, G Sarris, N Kolliarakis, I Economou, P Karageirgus, N Throuvalas page 114 Full-Text PDF (139 KB)
Quantitative description of dose conformality achieved by gamma knife radiosurgery compared to linac radiosurgery J.S Lee, L.J Verhey, V Smith, P.L Petti, K.R Lamborn, D.A Larson, W.M Wara, M McDermott, P.K Sneed pages 114-115 Full-Text PDF (253 KB)
MR-Spectroscopy results in improved target delineation for high-grade gliomas A Pirzkall, D.A Larson, T.R McKnight, E.E Graves, S.J Nelson, L.J Verhey page 115 Full-Text PDF (114 KB)
Risk of bleeding after radiosurgery of cerebral arteriovenous malformations (AVM) J Debus, S Swiderski, I Zuna, M Bahner, C Thilmann, O Jansen, M Wannenmacher page 116 Full-Text PDF (143 KB)
Cognitive functions in patients with cerebral arteriovenous malformations (AVMS) after radiosurgery: A long term follow up S Steinvorth, F Wenz, M Fuss, S Wildermuth, M Essig, W Hacke, M Wannenmacher, J Debus pages 116-117 Full-Text PDF (248 KB)
A prospective study of neuropsychologic testing and quality of life assessment of adults with primary malignant CNS tumors C.A Hahn, R.H Dunn, P.E Logue, J.H King, C.L Edwards, E.C Halperin page 117 Full-Text PDF (105 KB)
Neuropsychological effects of fractionated, stereotactic radiation therapy (FSRT) in patients with menigiomas G Welzel, S Steinvorth, F Wenz, M F??hler, W Hacke, J Debus, M Wannenmacher pages 117-118 Full-Text PDF (223 KB)
Comparison of pathologic response among three pre-operative chemoradiation regimens for resectable, locally advanced stomach cancer R Gopal, N Janjan, J Ajani, L Ho, S Hamilton, K Cleary, R Dubrow, B Feig, P Pisters, A Lowy, P Mansfield, C Crane page 118 Full-Text PDF (118 KB)
Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer M.R Baeza, O Giannini, R Rivera, P Gonzalez, J Gonzalez, E Vergara, C del Castillo, J Madrid page 119 Full-Text PDF (119 KB)
Adjuvant and neoadjuvant radiochemotherapy for advanced rectal cancer - first results of the German multicenter phase-III-trial R Sauer, R Fietkau, P Martus, R Raab, C Roedel, C Wittekind page 119 Full-Text PDF (119 KB)
A phase II trial of preoperative radiotherapy with protracted infusion 5-fluorouracil for resectable adenocarcinoma of rectum. A multi-center trial for the Trans-Tasman Radiation Oncology Group S.Y Ngan, B.H Burmeister, R Fisher, D Rischin, D.J Schache, A Kneebone, J.R Mackay, D.J Joseph, A Bell, D Goldstein pages 119-120 Full-Text PDF (264 KB)
Local excision and post-operative radiotherapy for rectal carcinoma R Benson, S Wong, B Cummings, J Brierley, P Catton, J Ringash, M Abdolell page 120 Full-Text PDF (145 KB)
Capecitabine combined with simultaneous radiotherapy in rectal cancer: A phase-I-study T Reese, J Tanner, S Frings, J Dunst pages 120-121 Full-Text PDF (267 KB)
Evidence for tumour site and gender-specific survival benefit from adjuvant chemotherapy in colorectal cancer: Molecular predictive markers come of age H Elsaleh, F Grieu, D Joseph, B Iacopetta page 121 Full-Text PDF (121 KB)
Microsatellite instability predicts for tumor response in a prospective trial of preoperative 5-FU, CPT-11 and radiation for locally advanced rectal cancer P.R Anne', T Bocker Edmonston, D Rose, S Burkholder, E.M Mitchell, A Kovatich, J Palazzo, B Boman, R Fry, W.J Curran, R Fishel pages 121-122 Full-Text PDF (186 KB)
Pathologic downstaging of T3-4 NX rectal cancer after chemo-radiation: 5-FU vs tegafur F.V Calvo, P Marcos, M Gomez-Espi, R Canlapiedra, R Herranz, E Alvarez page 122 Full-Text PDF (67 KB)
Intravaginal high dose rate brachytherapy for uterine-confined endometrial cancer A.B McKee, K.M Alektiar, M.J Zelefsky, B.R Mychalczak, B.J McKee, O Lin, R.R Barakat pages 122-123 Full-Text PDF (168 KB)
Figo stage IIIC endometrial cancer patients undergoing surgery and adjuvant radiation therapy K Murphy, P.P Connell, R.B McBride, A.J Mundt page 123 Full-Text PDF (100 KB)
The role of whole abdominal radiation therapy in the management of advanced endometrial cancer K Ghosh, D Uyar, L.S Downs, L.A Padilla, L.F Carson, D Unger, K.E Dusenbery pages 123-124 Full-Text PDF (243 KB)
Pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients following adjuvant chemotherapy alone: implications for locoregional radiation therapy A.J Mundt, R.B McBride, P.P Connell page 124 Full-Text PDF (142 KB)
Treatment morbidity in patients with endometrial cancer: results from a multicenter randomized trial C.L Creutzberg, W.L van Putten, P.C Koper, M.L Lybeert, J.J Jobsen, C.C Warlam-Rodenhuis, K.A De Winter, L.C Lutgens, A.C van den Bergh, E van de Steen-Banasik, H Beerman, M van Lent pages 124-125 Full-Text PDF (274 KB)
Vascular endothelial growth factor (VEGF) in sera and plasma of tumor-patients and the impact of hemogobin J Dunst, E Fischer, S Markau, A Becker, G Haensgen page 125 Full-Text PDF (131 KB)
Cost analysis of erythropoietin versus blood transfusions for cervix cancer patients receiving chemoradiotherapy B.D Kavanagh, R.M Cardinale, J.B Wheelock, E.M Segreti, S.H Benedict, A Goram pages 125-126 Full-Text PDF (275 KB)
Radiation-induced pelvic bone complications: An underestimated sequelae of pelvic irradiation B.A Erickson, K.J Murray, S.J Erickson, G.F Carrera page 126 Full-Text PDF (144 KB)
Patterns of failure in carcinoma of the vagina treated with definitive radiotherapy alone: What is the appropriate field volume? A.M Yeh, R.B Marcus, R.J Amdur, R.R Million pages 126-127 Full-Text PDF (266 KB)
Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) Y.E Erdi, E.D Yorke, A.K Erdi, L Braban, Y Hu, H Macapinlac, J.L Humm, S.M Larson, K Rosenzweig page 127 Full-Text PDF (122 KB)
Biological target volume (BTV) determined with dose response data from the correlation between metabolic rate of glucose (MRG) measured with 18F-FDG PET and pathologic complete response (PCR) in stage III non-small cell lung cancer (NSCLC) N.C Choi, A Fischman, S Aquino, A Niemierko, M Ancukiewicz pages 127-128 Full-Text PDF (268 KB)
High rate of detection of unsuspected distant metastases by pet in apparent stage III non small cell lung cancer: Implications for radical radiation therapy M.P Mac Manus, R Hicks, J.P Matthews, A Hogg, A McKenzie, A Wirth, R Ware, D.L Ball page 128 Full-Text PDF (146 KB)
Interobserver variation in contourinig gross tumour volume in carcinoma of the lung associated with pneumonitis and atelectasis: The impact of 18FDG-hybrid pet fusion J.B. Balogh, C.B. Caldwell, Y.C. Ung, K. Mah, C.E. Danjoux, S.N. Ganguli, L.E. Ehrlich pages 128-129 Full-Text PDF (258 KB)
Effect of inhomogeneities in small fields: Dosimetric implications for complex IMRT of lung R.K Mitra, D Mah, I.J Das, B Movsas, T.E Schultheiss page 129 Full-Text PDF (112 KB)
Gross tumor volume is an independent predictor of survival in non-small cell lung carcinoma patients treated with conformal radiotherapy J.D. Bradley, J.O. Deasy, J.A. Purdy, T.H. Wasserman, M.V. Graham, N. Ieumwananonthachai, M.A. Lockett pages 129-130 Full-Text PDF (257 KB)
Image fusion of F-18 FDG pet and CT.- is there a role in 3D-radiation treatment planning of non-small cell lung cancer? M Schmuecking, K Plichta, E.C Lopatta, C Przetak, J Leonhardi, D Gottschild, T.G Wendt, R.P Baum page 130 Full-Text PDF (145 KB)
The time course of radiation therapy-induced reductions in regional perfusion: A prospective study > 5 years of follow up R.T Woel, M.T Munley, M Fan, D Hollis, G Bentel, M.S Anscher, T.D Shafman, R.E Coleman, R.J Jaszczak, L.B Marks pages 130-131 Full-Text PDF (241 KB)
Recovery of pulmonary function in patients receiving thoracic radiotherapy for thoracic malignancies D.B Einstein, P Rubin, P Okunieff, T Smudzin, Y Chen page 131 Full-Text PDF (99 KB)
Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model M.W. Dewhirst, S. Walenta, S. Snyder, W. Mueller-Klieser, R. Braun, B. Chance pages 131-132 Full-Text PDF (241 KB)
Degranulation of mast cells correlates to radiation-induced increase of vascular permeability K.R Park, D Fukumura, W Monsky, C.G Lee, Y Boucher, R.K Jain, H.D Suit page 132 Full-Text PDF (144 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
